Asset Details
Do you wish to reserve the book?
Nanoparticle-Mediated Pulmonary Drug Delivery: A Review
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Nanoparticle-Mediated Pulmonary Drug Delivery: A Review
Do you wish to request the book?
Nanoparticle-Mediated Pulmonary Drug Delivery: A Review
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Nanoparticle-Mediated Pulmonary Drug Delivery: A Review
2014
Overview
Colloidal drug delivery systems have been extensively investigated as drug carriers for the application of different drugs via different routes of administration. Systems, such as solid lipid nanoparticles, polymeric nanoparticles and liposomes, have been investigated for a long time for the treatment of various lung diseases. The pulmonary route, owing to a noninvasive method of drug administration, for both local and systemic delivery of an active pharmaceutical ingredient (API) forms an ideal environment for APIs acting on pulmonary diseases and disorders. Additionally, this route offers many advantages, such as a high surface area with rapid absorption due to high vascularization and circumvention of the first pass effect. Aerosolization or inhalation of colloidal systems is currently being extensively studied and has huge potential for targeted drug delivery in the treatment of various diseases. Furthermore, the surfactant-associated proteins present at the interface enhance the effect of these formulations by decreasing the surface tension and allowing the maximum effect. The most challenging part of developing a colloidal system for nebulization is to maintain the critical physicochemical parameters for successful inhalation. The following review focuses on the current status of different colloidal systems available for the treatment of various lung disorders along with their characterization. Additionally, different in vitro, ex vivo and in vivo cell models developed for the testing of these systems with studies involving cell culture analysis are also discussed.
Publisher
MDPI AG,Molecular Diversity Preservation International (MDPI)
Subject
/ Animals
/ Anti-Asthmatic Agents - administration & dosage
/ Antineoplastic Agents - administration & dosage
/ Humans
/ Lung Diseases - drug therapy
/ Nanocapsules - adverse effects
/ Nanocapsules - therapeutic use
/ Nanoconjugates - adverse effects
/ Nanoconjugates - therapeutic use
/ Review
/ Toxicity
